BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 26539645)

  • 1. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
    Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
    Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity.
    Win S; Than TA; Le BH; García-Ruiz C; Fernandez-Checa JC; Kaplowitz N
    J Hepatol; 2015 Jun; 62(6):1367-74. PubMed ID: 25666017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
    Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC
    J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes.
    Pilar Valdecantos M; Prieto-Hontoria PL; Pardo V; Módol T; Santamaría B; Weber M; Herrero L; Serra D; Muntané J; Cuadrado A; Moreno-Aliaga MJ; Alfredo Martínez J; Valverde ÁM
    Free Radic Biol Med; 2015 Jul; 84():263-278. PubMed ID: 25841776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis.
    Rahman K; Liu Y; Kumar P; Smith T; Thorn NE; Farris AB; Anania FA
    Lab Invest; 2016 Aug; 96(8):895-908. PubMed ID: 27239734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
    Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
    Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
    Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
    Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
    Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress.
    Wang K; Li C; Lin X; Sun H; Xu R; Li Q; Wei Y; Li Y; Qian J; Liu C; Zhang Q; Yu S; Cui Z; Huang X; Zhu B; Zhou J; Mao C
    Cell Death Dis; 2020 Jan; 11(1):28. PubMed ID: 31949129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.
    Kakazu E; Mauer AS; Yin M; Malhi H
    J Lipid Res; 2016 Feb; 57(2):233-45. PubMed ID: 26621917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity.
    Lim A; Zhou J; Sinha RA; Singh BK; Ghosh S; Lim KH; Chow PK; Woon ECY; Yen PM
    Biochem Biophys Res Commun; 2016 Oct; 479(3):476-481. PubMed ID: 27651333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
    PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
    Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
    Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis.
    Seeßle J; Liebisch G; Schmitz G; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2015 May; 1851(5):549-65. PubMed ID: 25603556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis.
    Fucho R; Martínez L; Baulies A; Torres S; Tarrats N; Fernandez A; Ribas V; Astudillo AM; Balsinde J; Garcia-Rovés P; Elena M; Bergheim I; Lotersztajn S; Trautwein C; Appelqvist H; Paton AW; Paton JC; Czaja MJ; Kaplowitz N; Fernandez-Checa JC; García-Ruiz C
    J Hepatol; 2014 Nov; 61(5):1126-34. PubMed ID: 24946279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
    Dasgupta D; Nakao Y; Mauer AS; Thompson JM; Sehrawat TS; Liao CY; Krishnan A; Lucien F; Guo Q; Liu M; Xue F; Fukushima M; Katsumi T; Bansal A; Pandey MK; Maiers JL; DeGrado T; Ibrahim SH; Revzin A; Pavelko KD; Barry MA; Kaufman RJ; Malhi H
    Gastroenterology; 2020 Oct; 159(4):1487-1503.e17. PubMed ID: 32574624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
    Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
    World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.